Location History:
- Caldwell, NJ (US) (1985)
- North Caldwell, NJ (US) (1978 - 1994)
- N. Caldwell, NJ (US) (1994 - 1995)
Company Filing History:
Years Active: 1978-1995
Title: Ronald A. LeMahieu: Innovator in Pharmaceutical Chemistry
Introduction: Ronald A. LeMahieu, based in North Caldwell, NJ, is a prominent figure in the field of pharmaceutical chemistry. With a remarkable portfolio that includes 24 patents, he has made significant contributions to the development of novel therapeutic compounds aimed at treating various inflammatory diseases.
Latest Patents: Ronald's latest patents encompass pivotal innovations, including intermediates for the production of N-substituted anilines and compounds that act as potent inhibitors of phospholipases A2 (PLA2s). These innovative compounds are particularly valuable for the treatment of conditions such as psoriasis, inflammatory bowel disease, asthma, allergies, arthritis, dermatitis, gout, and myocardial ischemia/reperfusion. The therapeutic potential of these compounds is further enhanced when derivatives that are pharmaceutically acceptable salts with bases are developed. Another notable patent involves substituted benzoic acids as inhibitors of phospholipases A2, highlighting Ronald's commitment to addressing complex health issues through innovative chemical solutions.
Career Highlights: Ronald A. LeMahieu has built a distinguished career at Hoffmann-La Roche Inc., a leading entity in the pharmaceutical industry. His research and development efforts have focused on creating novel compounds that offer new treatments for challenging medical conditions, showcasing his capability to bridge the gap between innovative chemistry and practical medical application.
Collaborations: Throughout his career, Ronald has collaborated with esteemed colleagues, including Ru-Jen L. Han and Matthew Carson. These partnerships have fostered an environment of shared knowledge and expertise, leading to advancements in pharmaceutical innovation and contributing to the success of their joint research efforts.
Conclusion: Ronald A. LeMahieu stands out as a dedicated inventor whose work has the potential to make a significant impact on the health sector. His ongoing innovations in pharmaceutical intermediates and inhibitors of phospholipases A2 demonstrate his commitment to improving therapeutic options for patients. As he continues his work at Hoffmann-La Roche Inc., the medical community eagerly anticipates further advancements arising from his research endeavors.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.